Edgewise Therapeutics Inc (EWTX)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
CEO: | Kevin Koch |
Employees: | 60 |
Web site: | edgewisetx.com |
1715 38TH ST, BOULDER, CO, 80301
720-262-7002
|
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Edgewise Therapeutics, Inc. develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy.